Ultane 250 mL/250mL

Ultane 250 mL/250mL is a liquid inhalation anesthetic containing sevoflurane. It is commonly used for induction and maintenance of general anesthesia in surgical procedures. This product is manufactured by AbbVie Inc. in the USA.

Sevoflurane, the active ingredient in Ultane, is primarily used as an inhalation anesthetic. It is often employed to induce and maintain general anesthesia during surgical procedures. The liquid form is designed for respiratory administration, providing controlled and precise dosing for medical professionals.

Ultane 250 mL/250mL is designed to induce a state of general anesthesia, which typically results in unconsciousness and loss of pain sensation. The effects are intended to be temporary and reversible, allowing patients to regain consciousness after the procedure. Common side effects may include respiratory depression and changes in blood pressure.

Ultane should be handled with care, as it is intended for use by trained medical professionals only. Proper ventilation and safety measures should be in place during administration. Patients with a history of malignant hyperthermia or other anesthesia-related complications should be monitored closely.

Sevoflurane may interact with other anesthetics, muscle relaxants, and certain medications that affect the central nervous system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other sedatives should be avoided before and after administration.